Ultimovacs ASA: Notice of Annual General Meeting on 21 April 2022
Oslo, 25 March 2022, the Board of Directors hereby calls for the Annual General Meeting…
Oslo, 25 March 2022, the Board of Directors hereby calls for the Annual General Meeting…
Oslo, 25 March 2021: Ultimovacs ASA (“Ultimovacs”, ticker ULTI), a clinical stage leader in immune…
First data showing OCREVUS treatment effect on disability progression in non-active secondary progressive multiple sclerosis…
*** Unofficial English translation – For convenience purposes only *** UCB SA/NV – Public Limited…
Tokyo and Salt Lake City, Indianapolis, Mar 25, 2022 – (JCN Newswire) – Hitachi, Ltd….
HONG KONG, Mar 25, 2022 – (ACN Newswire) – ZhongAn Online P & C Insurance…
MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) — AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical…
COPENHAGEN, Denmark, March 24, 2022 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
HONG KONG, Mar 25, 2022 – (ACN Newswire) – Redsun Services Group Limited (“Redsun Services”…
HONG KONG, Mar 25, 2022 – (ACN Newswire) – Angelalign Technology Inc. (“Angelalign” or “Company”;…
NEW YORK–(BUSINESS WIRE)–Blackstone Mortgage Trust, Inc. (NYSE: BXMT) (the “Company”) today announced the pricing of…
Singapore, Mar 25, 2022 – (ACN Newswire) – Their gender itself is reason enough for…
Singapore, Mar 25, 2022 – (ACN Newswire) – Memiontec Holdings Ltd. (“Memiontec” or the “Company”,…
Customers will continue to be served through their respective Citizens and Investors branches, websites and…
Personalis’ oncology diagnostics business expected to build on foundation of advanced technology already the driver…
UserTesting helps companies innovate new ways to engage with customers as digital transformation continues to…
FORT COLLINS, Colo., March 24, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
Continued Progress Towards Optimizing Clinical Development Plans On Track to Initiate Phase 2b Study of…
— Proposal of one-tier board structure & appointment of three new directors — Mechelen, Belgium;…
Pipeline Advancement Continues with Ongoing Phase 2 Studies for Voriconazole and Tacrolimus Programs Partnership Activity…